Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase β in their mammary glands

Carcinogenesis

Volumn 28, Issue 6, 2007, Pages 1356-1363

  Wang, Liming ^a   Bhattacharyya, Nandan ^b   Rabi, Thangaiyan ^a   Wang, Li ^a   Banerjee, Sipra ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HALDIA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PROTEIN; DNA DIRECTED DNA POLYMERASE BETA; DNA DIRECTED DNA POLYMERASE DELTA; METHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; FIBROBLAST; MAMMARY GLAND; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE; TUMOR RECURRENCE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; CATTLE; CELL LINE, TRANSFORMED; DNA POLYMERASE BETA; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, NUDE; MICE, TRANSGENIC;

EID: 34447324659     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl239     Document Type: Article

References (42)

1. Wilson,S.H. (1998) Mammalian base excision repair and DNA polymerase beta. Mutat. Res., 407, 203-215.
2. Memisogmson,L. (2000) Base excision repair in yeast and mammals. Mutat. Res., 451, 39-51.
3. Feig,D.I. et al. (1993) Mechanisms of mutation by oxidative DNA damage: Reduced fidelity of mammalian DNA polymerase β. Biochemistry 32, 4466-4473.
4. Dianov,G.L. et al. (2000) Single nucleotide patch base excision repair is the major pathway for removal of thymine glycol from DNA in human cell extracts. J. Biol. Chem., 275, 11809-11813.
5. Pascucci,B. et al. (2002) Reconstitution of the base excision repair pathway for 7, 8-dihydro-8-oxoguanine with purified human proteins. Nucleic Acids Res., 30, 2124-2130.
6. Sobol,R.W. et al. (1996) Requirement of mammalian DNA polymerase β in base-excision repair. Nature, 379, 183-186.
7. Matsumoto,Y. et al. (1995) Excision of deoxyribose phosphate residues by DNA polymerase β during DNA repair. Science, 269 699-702.
8. Prasad,R. et al. (1998) Human DNA polymerase β deoxyribose phosphate lyase. Substrate specificity and catalytic mechanism. J. Biol. Chem., 273, 15263-15270.
9. Allison,S.L. et al. (2001) DNA polymerase β is the major dRP lyase involved in repair of oxidative base lesions in DNA by mammalian cell extract. EMBO J, 20, 6990-16926.
10. Sweasy,J.B. et al. (1993) Detection and characterization of mammalian DNA polymerase β mutants by functional complementation in Escherichia coli. Proc. Natl Acad. Sci. USA, 90, 4626-4630.
11. Gu,H. et al. (1994) Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science, 265, 103-106.
12. Sugo,N. et al. (2000) Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. EMBO J, 19, 1397-1404.
13. Plug,A.W. et al. (1970). Evidence for a role for DNA polymerase β in mammalian meiosis. Proc. Natl Acad. Sci. USA, 94, 1327-1331.
14. Ochs,K. et al. (1999) Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage. Cancer Res., 59, 1544-1551.
15. Ali-Osman,F. et al. (1994) Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases α and β, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy. J. Cell. Biochem., 54, 11-19.
16. Fotiadou,P. et al. (2004) DNA polymerase beta interacts with TRF2 and induces telomere dysfunction in a murine mammary cell line. Cancer Res., 64, 3830-3837.
17. Lang,T. et al. (2004) A DNA polymerase beta mutant from colon cancer cells induces mutations. Proc. Natl Acad. Sci. USA, 101 6074-6079.
18. Wang,L. et al. (1992) DNA polymerase β mutations in human colorectal cancers. Cancer Res., 52, 4824-4827.
19. Wang,L. et al. (1995) Mutations in DNA polymerase β occur in breast, prostate and colorectal cancers. Int. J. Oncol., 6, 459-463.
20. Bhattacharyya,N. et al. (1999) Alteration of hMSH2 and DNA polymerase β genes in breast carcinomas and fibroadenomas. Biochem. Biphys. Res. Commun., 259, 429-435.
21. Bhattacharyya,N. et al. (1999) Variant forms of DNA po1β in primary lung carcinomas. DNA Cell Biol., 18, 549-554.
22. Chen,H.C. et al. (2000) Defective repair genes in a primary culture of human renal cell carcinoma. J. Cancer Res. Clin. Oncol. 126, 185-190.
23. Bhattacharyya,N. et al. (1997) A variant of DNA polymerase β acts as a dominant negative mutant. Proc. Natl Acad Sci. USA, 94, 10324-10329.
24. Dobashi,Y. et al. (1994) DNA polymerase β gene mutation in human prostate cancer. Cancer Res., 54, 2827-2829.
25. Matsuzaki,J. et al. (1996) DNA polymerase β gene mutations in human bladder cancer. Mol. Carcinog, 15, 38-43.
26. Iwanaga,A. et al. (1999) Functional mutation of DNA polymerase beta found in human gastric cancer-inability of the base excision repair in vitro. Mutat. Res., 435, 121-128.
27. Bhattacharyya,N. et al. (2003) Mutations occur in the genomic sequence of the DNA polymerase β of ovarian cancer. Proc. Am. Assoc. Cancer Res., 44, 261.
28. Bhattacharyya,N. et al. (2001) Impaired repair activity of a truncated DNA polymerase β protein. Life Sci., 69, 271-280.
29. Bhattacharyya,N. et al. (2001) A novel role of XRCC1 in the functions of a DNA polymerase β variant. Biochemistry, 40, 9005-9013.
30. Banerjee,S. et al. (2005) Neoplastic activity and chromosomal alterations of cells expressing a DNA polymerase beta mutant. Proc. Am. Assoc. Cancer Res., 46, (abstract no. 1779).
31. Banerjee,S. et al. (1986) In vitro transformation of C3H/ 10T1/2 and NIH/3T3 cells by acrylonitrile and acrylamide. Cancer Lett., 32, 293-304.
32. Schultz,K. et al. (1992) Neoplastic expression in murine cells induced by halogenated hydrocarbons. In Vitro Cell. Dev. Biol., 28A, 267-272.
33. Bergoglio,V. et al. (2004) Evidence of finely tuned expression of DNA polymerase β in vivo using transgenic mice. FEBS Lett, 566, 147-150.
34. Bhattacharyya,N. et al. (2002) Heterogeneity in expression of DNA polymerase β and DNA repair activity in human tumor cell lines. Gene Expr., 10, 115-123.
35. Bayna,E. et al. (1990) Tissue-specific, high-level expression of the rat whey acidic protein gene in transgenic mice. Nucleic Acid Res., 18, 2977-2985.
36. Li,B. et al. (1998) A transgenic mouse model for mammary carcinogenesis. Oncogene, 16, 997-1007.
37. Murphy,K,L. et al. (1999) Bc1-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice. Oncogene, 18, 6597-6604.
38. Medina,D. (1974) Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB/c and C57B1 mice. J. Natl Cancer Inst., 53, 213-221.
39. Swanson,S.M. et al. (1994) Pituitary-isografted mice are highly susceptible to MNU-induced mammary carcinogenesis irrespective of the level of alveolar differentiation. Carcinogenesis, 15, 1341-1346.
40. Wang,L. et al. (2004) A novel nuclear protein, MGC5306 interacts with DNA polymerase β and has a potential role in cellular phenotype. Cancer Res., 64, 7673-7677.
41. Sweasy,J.B. et al. (2005) Expression of DNA polymerase β cancer-associated variants in mouse cells results in cellular transformation. Proc. Natl Acad. Sci. USA, 102, 14350-14355.
42. Hennighausen,L. et al. (1994) Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development. Cell Growth Differ, 5, 607-613.